BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA upgrades Cadila Healthcare to buy
CLSA has upgraded Cadila Healthcare to 'buy" from "underperform" and revised target price on the stock to Rs 470 from Rs 360 earlier.